Literature DB >> 12518326

Quantitation of apoptotic activity following castration in human prostatic tissue in vivo.

Andrea Staack1, Adrienne P Kassis, Adam Olshen, Yuzhuo Wang, David Wu, Peter R Carroll, Gary D Grossfeld, Gerald R Cunha, Simon W Hayward.   

Abstract

BACKGROUND: Androgen deprivation induces apoptosis in the prostate. Representative data, quantitating apoptotic activity in human prostatic epithelium following androgen ablation, are lacking.
METHODS: Human prostatic tissue was grafted beneath the renal capsule of intact male athymic mice and allowed to become established. The mice were castrated and specimens were harvested on post-castration day 0, 1, 2, 3, 4, 5, 7, 8, 9, 10, 14, 17, 18, and 21. Tissue was immediately fixed and apoptotic epithelial nuclei were identified.
RESULTS: The percentage of terminal deoxynucleotidyl-transferase-mediated dUTP nick end-labeling (TUNEL) positive epithelial cells increased from a baseline of 0.026%, peaked on post-castration day 3 (1.54%), and returned to baseline by day 21. Mathematical analysis predicted that the observed apoptotic activity account for the loss of 87% of prostatic epithelial cells in 3 weeks.
CONCLUSIONS: Post-castration apoptosis in human prostatic epithelium was low but was sufficient to account for the loss of nearly 90% of epithelial cells. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12518326     DOI: 10.1002/pros.10179

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

1.  Tissue slice grafts: an in vivo model of human prostate androgen signaling.

Authors:  Hongjuan Zhao; Rosalie Nolley; Zuxiong Chen; Donna M Peehl
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity.

Authors:  Silvana G P Campos; Bianca F Gonçalves; Wellerson R Scarano; Lara S Corradi; Fernanda C A Santos; Ana M G Custodio; Patricia S L Vilamaior; Rejane M Góes; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

Review 3.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

4.  Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

Authors:  Harold D Love; S Erin Booton; Braden E Boone; Joan P Breyer; Tatsuki Koyama; Monica P Revelo; Scott B Shappell; Jeffrey R Smith; Simon W Hayward
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

5.  Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer.

Authors:  Douglas G McNeel; Heath A Smith; Jens C Eickhoff; Joshua M Lang; Mary Jane Staab; George Wilding; Glenn Liu
Journal:  Cancer Immunol Immunother       Date:  2011-12-31       Impact factor: 6.968

6.  Proliferative, structural and molecular features of the Mdx mouse prostate.

Authors:  Leslie C Pinto; Wagner J Fávaro; Valéria H A Cagnon
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

7.  Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses.

Authors:  Matthew D Morse; Douglas G McNeel
Journal:  Hum Immunol       Date:  2010-03-05       Impact factor: 2.850

Review 8.  Human benign prostatic hyperplasia heterotransplants as an experimental model.

Authors:  Lluis-A Lopez-Barcons
Journal:  Asian J Androl       Date:  2009-11-30       Impact factor: 3.285

Review 9.  The basic biochemistry and molecular events of hormone therapy.

Authors:  Elahe A Mostaghel; Robert B Montgomery; Daniel W Lin
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

10.  Proliferation and apoptotic rates and increased frequency of p63-positive cells in the prostate acinar epithelium of alloxan-induced diabetic rats.

Authors:  Fanny Oliveira Arcolino; Daniele Lisboa Ribeiro; Marina Guimarães Gobbo; Sebastião Roberto Taboga; Rejane Maira Góes
Journal:  Int J Exp Pathol       Date:  2009-12-22       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.